Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study.

BMC Surg · 2023 · PMC10170768 · PMID 37161374

Europe PMC DOI

hedged sentence

0.0640

closest p · 1.3× alpha

0.0640

boldest claim

The sentences

only marginally significantP = 0.064so close (0.05 < p ≤ 0.1)

363.6 ± 11.8 min); however, the difference was only marginally significant (P = 0.064).

also in 5,072 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.